The shares shot up from the low 4's to mid 5's in just a few days. I suspect there was and is some profit sharing from short term holders of the company. Moreover, perhaps others have taken money off the table before the PDUFA date next week. What do you think?
so is it unrealistic to assume that those physicians will be able to have just 10 patients on PB soon? This seems to be quite reasonable especially when the word gets around about the medication's effectiveness. Why can't we have 20,000 patients being treated in the next quarter or two?
I don't know how we could have wished for a better start to the launch:
"We look forward to educating qualified healthcare providers in New Orleans on July 8, 9 and 10 on best practices for insertion and removal of Probuphine, the only treatment for opioid dependence that delivers medicine for up to six months. In the first four weekends, we certified 1,388 healthcare providers to provide the treatment to their patients."
Jr: I have appreciated your posts on this board. I do not think the threat of a lawsuit is anything meaningful. I disagree that it will be dead money for a long time. I encourage you to take a deep breath. $5.50 or thereabout is probably as low as the SP will go. Braeburn has a lot of skin in the game to make a successful launch. And I think the launch will be successful. They have done everything possible to get it up and running. I think the market is taking a skeptical approach on market adoption of the product. But the product is a potential game changer, no matter what injectable forms of what medication is coming. To not think about taking pills or receiving injections for six months is a big deal when you are dealing with recovery issues. So I think this will pick up sooner rather than later.